ECT is contributing to the SETAC Europe 29th Annual Meeting ‘One environment. One health. Sustainable societies’ that takes place in Helsinki, Finland, from May 26th to 30th, 2019. It addition to the presentations and activities indicated below, ECT presents its work at booth number 29.
The persistence assessment under REACH relies on compartment‐specific degradation half‐lives derived from laboratory simulation studies with surface water, aquatic sediment or soil. Although these data are given priority, they are not available for most of the compounds. Therefore, according to the integrated assessment and testing strategy for persistence assessment, results from ready biodegradability tests are […]
The two-day international conference ‘New approaches for prioritisation and assessment of the risks of pharmaceuticals in the environment’ will mark the end of the IMI-funded project ‘Intelligence-led assessment of pharmaceuticals in the environment’ (iPiE). The conference will take place on 24-25 June 2019 at the University of York (UK). It will provide an overview on […]
The project Intelligence-led assessment of pharmaceuticals in the environment (iPiE) will be presented at the SETAC Europe Annual Meeting in Helsinki, at a symposium organised by the SETAC Europe Pharmaceutical Interest Group. The symposium will take place on Sunday, 26 May 2019 (13:00 – 17:30). Its aim is to present the iPiE project in detail […]
The SETAC World Council recently approved the nomination of Anja Coors as member of the editorial board of Environmental Toxicology and Chemistry (ET&C).
In its annual list of high ranking reviewers, Environmental Toxicology and Chemistry (ET&C) highlights reviewers who have consistently provided the journal with high‐quality, timely reviews.
The interaction of pollutants and pathogens may result in altered (often enhanced) effects of the chemical, the biotic stressor or both. While standardised detection methods for immunotoxic effects of chemicals exist with regard to human health, such test systems are lacking for invertebrate species and no guidance is available on how immunotoxic effects of a […]
ECT is involved in the project ‘Intelligence-led assessment of pharmaceuticals in the environment’ (iPiE). The iPiE project contributes to developing frameworks for intelligence-based environmental testing of pharmaceuticals and for prioritising legacy pharmaceuticals for targeted environmental risk assessment and environmental (bio-) monitoring. The current iPiE newsletter (Newsletter No 6) features an interview with Anja Coors, who […]
Few suitable and standardised test methods are currently available to test the effects of genetically modified plants (GMP) on non-target organisms. To fill this gap and improve ecotoxicological testing for GMP, we developed a new soil ecotoxicological test method using sciarid larvae as test organisms. Bradysia impatiens was identified as a candidate species. A functional […]
The United Nations’ sustainable development goals have been established to end poverty, protect the planet, and ensure prosperity for all. Delivery of the sustainable development goals requires a healthy and productive environment. An understanding of the impacts of chemicals on environmental health is essential for sustainable environmental quality. However, current research on and regulation of […]
ECT Oekotoxikologie GmbH is a privately owned enterprise that was founded in 1993.
In compliance with Good Laboratory Practice (GLP), we perform standardised ecotoxicological tests in the laboratory as well as at semi-field and field level.
Find us at
ECT Oekotoxikologie GmbH
Böttgerstraße 2 – 14
65439 Flörsheim am Main
Phone: +49 6145 9564-0
Fax: +49 6145 9564-99